Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

Strategies to reduce disease burden in alpha- or beta-thalassemia, sickle cell disease, and polycythemia vera, and insights into anemia in IBD, are among anemia highlights from ASH 2024.

Vanda Pharmaceuticals Inc.’s VGT-1849A, a selective antisense oligonucleotide (ASO)-based JAK2 inhibitor, has been awarded ...

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) Friday announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849A, a selective antisense oligonucleotide ...

WOW! Internet, TV & Phone , a leading broadband services provider, today announced its all-fiber services are now available in Brighton, a town in Livingston County, Michigan. This is the first of ...

If you are interested in meeting with the Protagonist team during the conference, please reach out to your J.P. Morgan representative. A replay of the presentation will be available on the Company's ...

Vanda Pharmaceuticals (VNDA)’ treatment of polycythemia vera was granted FDA orphan designation, according to a post to the agency’s ...

A panelist discusses how polycythemia vera (PV) is a rare myeloproliferative neoplasm (MPN) characterized by excessive red ...

Articles on myeloproliferative neoplasms (MPNs) covered the debate over how early to use cytoreductive therapies instead of ...

Two researchers from Huntsman Cancer Institute at the University of Utah (the U) have discovered a gene variant found in high ...

The scene is cloaked in thick darkness. A crowd enthusiastically counts down. “3…2…1!” Bright resplendent light bursts forth! A Christmas tree and surrounding decorations shine with gleaming vivid ...

Dear Dr. Roach: I read your recent column on shingles. I am 66 years old and in fairly good health. I had both Shingrix shots ...